חזרה לתוצאות החיפוש

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Univ of California San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Brianna Garcia) · brianna.garcia2@ucsf.edu
    Contact: Principal Investigator (Lawren Vandevrede)

  • CenExcel Rocky Mtn Clin Research, Englewood, Colorado, United States

    Contact: Study coordinator (Jessica Crall) · j.crall@cenexel.com · +1 303 762 6674
    Contact: Principal Investigator (Meagen Salinas)

  • Mayo Jacksonville, Jacksonville, Florida, United States

    Contact: Study coordinator (Audrey Strongosky) · strongosky.audrey@mayo.edu · +1 904 953 2254
    Contact: Principal Investigator (Zbigniew K Wszolek)

  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Brenda Nelson) · nelson.brenda6@mayo.edu
    Contact: Principal Investigator (James Bower)

  • Novartis Investigative Site, Melbourne, Victoria, Australia

  • Novartis Investigative Site, Caen, France

  • Novartis Investigative Site, Créteil, France

  • Novartis Investigative Site, Paris, France

  • Novartis Investigative Site, Toulouse, France

  • Novartis Investigative Site, Bonn, North Rhine-Westphalia, Germany

  • Novartis Investigative Site, Düsseldorf, North Rhine-Westphalia, Germany

  • Novartis Investigative Site, Leipzig, Saxony, Germany

  • Novartis Investigative Site, Berlin, Germany

  • Novartis Investigative Site, Stadtroda, Germany

  • Klinik für Neurologie (Schwerpunkt Neurodegeneration), Ulm, Germany

    Contact: Study coordinator (Olga Vintonyak) · olga.vintonyak@uni-ulm.de
    Contact: Principal Investigator (Olga aVintonyak)

  • Novartis Investigative Site, Milan, MI, Italy

  • Novartis Investigative Site, Roma, RM, Italy

  • Novartis Investigative Site, Kodaira, Tokyo, Japan

  • Novartis Investigative Site, Rotterdam, South Holland, Netherlands

  • Novartis Investigative Site, Barcelona, Spain

  • Novartis Investigative Site, Las Palmas GC, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Seville, Spain

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)